Discovery Grant Review Panels

Note: Panel lists will be updated as panel members are recruited.


Four panels of experts will review the applications submitted to the 2017 competition:

Panel A: Biology of Prostate Cancer
Studies that will develop new knowledge to improve our understanding of the biology of prostate cancer may include prostate cancer initiation (gene expression, oncogenes), tumour progression and metastasis.
 
Bharati Bapat
Chair
Lunenfeld-Tanenbaum Research Institute, Sinai Health System
Toronto, ON
Juan Ausio University of Victoria
Victoria, BC
Nicolas Bisson Chu de Quebec Research Centre
Quebec, QC
Andrei Drabovich University Health Network
Toronto, ON
Michael Hallett Concordia University
Montreal, QC
Kensuke Hirasawa Memorial University of Newfoundland
St John's, NL
Madhuri Koti Queen's University
Kingston, ON
Robert Nabi University of British Columbia
Vancouver, BC
Linda Penn University Health Network
Toronto, ON
Thomas Simmen University of Alberta
Edmonton, AB
Eva Turley London Health Sciences Centre
London, ON
Andrei Drabovich
Scientific Officer
University Health Network
Toronto, ON
Randy Baldwin
Community Representative
Niverville, MB
Jo-Anne Phillips
Community Representative
Irishtown, NB
Note: This list will be updated as panel members are recruited.


Panel B: Early Detection of Prostate Cancer
Research that aims to identify, develop and test novel prostate cancer markers and imaging methods that are helpful in detecting and/or diagnosing cancer as well as predicting the outcome or chance of recurrence.
 
Katherine Zukotynski
Chair
McMaster University
Hamilton, ON
Chantal Autexier McGill University
Montreal, QC
Laura Curiel Thunder Bay Regional Health Research Institute
Thunder Bay, ON
Ralph DaCosta University Health Network
Toronto, ON
Housheng Hansen He University Health Network
Toronto, ON
Hon Leong Lawson Health Research Institute
London, ON
Bryan Lo University of Ottawa
Ottawa, ON
Sohrab Shah BC Cancer Agency
Vancouver, BC
Bobby Shayegan McMaster University
Hamilton, ON
Amina Zoubeidi University of British Columbia
Vancouver, BC
Bill Sutherland
Community Representative
Victoria, BC
Note: This list will be updated as panel members are recruited.


Panel C: Experimental Therapeutics
This panel will review applications in the area of the discovery and development of new anti-prostate cancer treatments and includes chemotherapy, hormone therapy, radiation therapy and surgery.
 
Gregory Pond
Chair
McMaster University
Hamilton, ON
Stanley Liu Sunnybrook Research Institute
Toronto, ON
Michael Ong University of Ottawa
Ottawa, ON
Thomas Sanderson Institut national de la recherche scientifique
Quebec, QC
Jian Hui Wu McGill University
Montreal, QC
Frank Wuest University of Alberta
Edmonton, AB
Geoffrey Gotto
Scientific Officer
University of Calgary
Calgary, AB
Kelly Fedorowich
Community Representative
Calgary, AB
Robert Mitchell
Community Representative
Edmonton, AB
Note: This list will be updated as panel members are recruited.


Panel D: Health systems, services, population and public health
Applications reviewed by this panel will include those studying interventions at the population level, with patients, survivors or other cohorts; epidemiological studies; research into the quality of life of those affected by prostate cancer; novel research to understand the etiology of prostate cancer; health services research related to prostate cancer.
 
Anne Katz
Chair
CancerCare Manitoba
Winnipeg, MB
Lisa Anllo Lisa Anllo, PhD LLC
Buffalo, NY, USA
Chris Blanchard Dalhousie University
Halifax, NS
Julian Kim CancerCare Manitoba
Winnipeg, MB
Girish Kulkarni University Health Network
Toronto, ON
Michael Leveridge Queen's University
Kingston, ON
Jon Tonita Saskatchewan Cancer Agency
Regina, SK
Gabriela Ilie
Scientific Officer
Dalhousie University
Halifax, NS
Kelly Keen
Community Representative
Edmonton, AB
Vince Schiralli
Community Representative
Vancouver, BC
Note: This list will be updated as panel members are recruited.




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada encouraged by growing political support for PSA test coverage in BC

Vancouver BC - April 11, 2017 - Prostate Cancer Canada (PCC) applauds the first provincial party in BC to announce their commitment to cover the cost of PSA (prostate-specific antigen) tests for men when ordered by a physician.
More

Taking fundraising to new heights: Canadians climb 5,000 feet for prostate cancer research

Toronto, ON - March 9, 2017 - Over the course of the last few weeks, corporate teams located in Vancouver, Calgary and Toronto raised more than $650,000 for prostate cancer research by competing in Prostate Cancer Canada’s (PCC) 4th annual Step Up Challenge, presented by Scotiabank.
More

Prostate Cancer Canada's Rock the Road Raffle sells out for 5th consecutive year

March 1, 2017 – TORONTO, ON – For the fifth year and counting, Prostate Cancer Canada’s (PCC) Rock the Road Raffle brought together Ontarians from all walks of life to both support an important cause and have a chance to win a one-of-a-kind dream car.
More


Click here for news archive